Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial

BACKGROUND: Alternate-day fasting (ADF) is a novel diet therapy that may achieve reduction in body weight and improvement of dyslipidaemia, but the impact of this diet on patients with non-alcoholic fatty liver disease (NAFLD) remains unknown. The aim of this study was to evaluate the effects of ADF...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Hua, Qin, Yue-Lan, Shi, Ze-Ya, Chen, Jin-Hui, Zeng, Min-Jie, Zhou, Wei, Chen, Ru-Qun, Chen, Zhi-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921505/
https://www.ncbi.nlm.nih.gov/pubmed/31852444
http://dx.doi.org/10.1186/s12876-019-1132-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921505/
https://www.ncbi.nlm.nih.gov/pubmed/31852444
http://dx.doi.org/10.1186/s12876-019-1132-8

Ejemplares similares